Different expression of μ-opiate receptor in chronic and acute wounds and the effect of β-endorphin on transforming growth factor β type II receptor and cytokeratin 16 expression

Journal of Investigative Dermatology

Volumn 120, Issue 1, 2003, Pages 145-152

  Bigliardi, P L ^a   Sumanovski, L T ^b   Buchner S ^b   Rufli, T ^b   Bigliardi Qi, M ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NONE

Author keywords

Chronic and acute wounds; Cytokeratin 16; Epidermis; TGF receptor II; Wound healing; opiate receptor; en dorphin

Indexed keywords

BETA ENDORPHIN; CYTOKERATIN 16; MU OPIATE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SKIN CULTURE; WOUND; WOUND HEALING;

EID: 0037242116     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12018.x     Document Type: Article

References (23)

1. Bigliardi PL, Bigliardi-Qi M, Büchner S, Rufli T: Expression of μ-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol 111:297-301, 1998
2. Bigliardi-Qi M, Bigliardi PL, Büchner S, Rufli T: Characterization of μ-opiate receptor in human epidermis and keratinocytes. Ann N Y Acad Sci 885:368-371, 1999
3. Bigliardi-Qi M, Bigliardi PL, Eberle AN, Büchner S, Rufli T: β-Endorphin stimulates cytokeratin 16 expression and downregulates μ-opiate receptor expression in human epidermis. J Invest Dermatol 114:527-532, 2000
4. Cui W, Fowlis DJ, Cousins FM, Duffie E, Bryson S, Balmain A, Akhurst RJ: Concerted action of TGF-β 1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev 9:945-955, 1995
5. Ferreira SH, Nakamura MII: Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 18:191- 200, 1979
6. Gerritsen MJ, Elbers ME, de Jong EM, van de Kerkhof PC: Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci 14:179-188, 1997
7. Gold LI, Sung JJ, Siebert JW, Longaker MT: Type I (RI) and type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol 150:209-222, 1997
8. Ito Y, Sarkar P, Mi Q, et al: Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-β-mediated epidermal homeostasis. Dev Biol 236:181-194, 2001
9. Joris JL, Dubner R, Hargreaves KM: Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth Analg 66:1277-1281, 1987
10. Kohl A, Werner A, Buntrock P, Diezel W, Adrian K, Titov MI: [The effect of the peptide dalargin on wound healing]. Dermatol Monatsschr 175:561-572, 1989
11. Levy EM, McIntosh T, Black PH: Elevation of circulating β-endorphin levels with concomitant depression of immune parameters after traumatic injury. J Trauma 26:246-249, 1986
12. Nissen JB, Lund M, Stengaard-Pedersen K, Kragballe K: Enkephalin-like immunoreactivity in human skin is found selectively in a fraction of CD68-positive dermal cells: increase in enkephalin-positive cells in lesional psoriasis. Arch Dermatol Res 289:265-271, 1997
13. Paus R, Lüftl M, Czarnetzki BM: Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol 130:174-180, 1994
14. Shekhter AB, Solov'eva AI, Spevak SE, Titov MI: Effects of opioid peptide dalargin on reparative processes in wound healing. Biull Eksp Biol Med 106:487-490, 1988
15. Slominski A, Wortsman J, Mazurkiewicz JE, et al: Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 122:658-666, 1993
16. Soledad Cepeda M, Lipkowski AW, Langlade A, et al: Local increases of subcutaneous β-endorphin immunoactivity at the site of thermal injury. Immunopharmacology 25:205-213, 1993
17. Twillman RK, Long TD, Cathers TA, Mueller DW: Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 17:288-292, 1999
18. Vethamany-Globus S, Globus M, Milton G: A comparison of β-endorphin levels in regenerating and nonregenerating vertebrates. J Exp Zool 227:475-479, 1983
19. Wang XJ: Role of TGF β signaling in skin carcinogenesis. Microsc Res Tech 52:420- 429, 2001
20. Wintzen M, Yaar M, Avila E, Vermeer BJ, Gilchrest BA: Keratinocytes produce β-endorphin and β-lipotropin hormone after stimulation by UV, IL-1α or phorbol esters. J Invest Dermatol 104:641, 1995
21. Xue JZ: [Changes in plasma immunoreactive β-endorphin in burn and its clinical significance]. Zhonghua Zheng Xing Shao ShangWai Ke Za Zhi 7:253-256 317, 1991
22. Zanello SB, Jackson DM, Holick MF: An immunocytochemical approach to the study of β-endorphin production in human keratinocytes using confocal microscopy. Ann N Y Acad Sci 885:85-99, 1999
23. Zhang X, Bao L, Shi TJ, Ju G, Elde R, Hokfelt T: Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82:223-240, 1998